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Hepatitis B virus (HBV) infection is widely distributed in both human and ape populations throughout the
world and is a major cause of human morbidity and mortality. HBV variants are currently classified into the
human genotypes A to H and species-associated chimpanzee and gibbon/orangutan groups. To examine the
role of recombination in the evolution of HBV, large-scale data retrieval and automated phylogenetic analysis
(TreeOrder scanning) were carried out on all available published complete genome sequences of HBV. We
detected a total of 24 phylogenetically independent potential recombinants (different genotype combinations or
distinct breakpoints), eight of which were previously undescribed. Instances of intergenotype recombination
were observed in all human and ape HBV variants, including evidence for a novel gibbon/genotype C recom-
binant among HBV variants from Vietnam. By recording sequence positions in trees generated from sequential
fragments across the genome, violations of phylogeny between trees also provided evidence for frequent
intragenotype recombination between members of genotypes A, D, F/H, and gibbon variants but not in B, C,
or the Asian B/C recombinant group. In many cases, favored positions for both inter- and intragenotype
recombination matched positions of phylogenetic reorganization between the human and ape genotypes, such
as the end of the surface gene and the core gene, where sequence relationships between genotypes changed in
the TreeOrder scan. These findings provide evidence for the occurrence of past, extensive recombination events
in the evolutionary history of the currently classified genotypes of HBV and potentially in changes in its global
epidemiology and associations with human disease.
Infection with hepatitis B virus (HBV) is globally distrib-
uted, infecting approximately one-third of the world’s human
population. It is responsible for substantial proportion of liver
disease that kills over one million people through uncompen-
sated liver disease or hepatocellular carcinoma each year (43).
Populations in South and East Asia, sub-Saharan Africa, and
Central and South America show particularly high frequencies
of HBV infection that may be maintained through mother-to-
child perinatal transmission (13) or horizontal transmission in
childhood (8, 41).
HBV variants infecting humans show genetic and antigenic
heterogeneity and are currently classified into seven or eight
genotypes that differ from each other in nucleotide sequence
by 10 to 13% (29–31, 33). While genotypes A, D, and possibly
G have global distributions, genotypes B and C are found
predominantly in East and Southeast Asia, genotype E is found
in West Africa, and genotypes F and H are found among
various population groups, including indigenous peoples in
Central and South America. Active and resolved HBV infec-
tions are also found at high frequencies in chimpanzees (17, 17,
24, 42, 45) and Southeast Asian apes (12, 28, 46, 49) with
species-associated HBV variants distinct from those found in
human populations. Finally, an HBV variant was recovered
from a captive woolly monkey (21), whose sequence is highly
divergent from all other human and ape sequences described
to date.
It is increasingly accepted that, in addition to the currently
classified genotypes of HBV, recombination between genotypes
generates novel variants that contribute to the genetic diversity of
HBV. Recombination in human HBV was first detected in se-
quential samples from infected individuals and among integrated
sequences from cases of hepatocellular carcinoma (11, 44). How-
ever, recombination between different genotypes was also sus-
pected from incongruities between phylogenetic trees constructed
from different regions of the HBV genome (30) and was formally
demonstrated through the identification of specific breakpoints in
certain published sequences, such as HBVDNA (4), proposed to
be a recombinant between genotypes A and D. Both the existence
of well-defined breakpoints and the exchange of large sections of
sequence between genotypes indicate that recombination, rather
than phenotypically selected accelerated evolution and/or conver-
gence (e.g., such as mediated by the immune system [22]), most
plausibly accounts for the existence of phylogenetic incongruities
between HBV variants in different parts of the genome.
Since then, using similar analytical methods, there have been
several published descriptions of intergenotype recombinants
among newly obtained or existing variants of HBV. Among
these, recombinant forms between A and D (5, 26, 34), B and
C (5, 26, 26, 27, 30, 40, 52), and C and D (7, 48) have been
identified. However, in many cases, recombinants may be sep-
arate instances of phylogenetically related viruses that have
become widely distributed geographically. For example, a re-
combinant generated through the exchange of the core gene of
genotype C into a genotype B variant, often described as ge-
notype Ba (with Bj designating nonrecombinant genotype B),
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has become prevalent in mainland East Asia and indepen-
dently recorded in several surveys (5, 26, 40).
In this study, we have sought to identify independent in-
tergenotype recombinants of HBV by large-scale screening
and phylogenetic analysis of complete genome sequences avail-
able in public sequence databases. Using a series of novel
phylogenetic and bioinformatic analysis methods, we have
mapped recombination hot spots to positions of phylogeny
rearrangements within currently classified HBV genotypes.
These findings, combined with the new evidence for extensive
recombination between members of the same genotype (in-
tragenotype recombination), provide new data on the central
role of recombination in the past evolution of HBV and in the
generation of its current genetic diversity.
MATERIALS AND METHODS
Nucleotide sequences. The study sequences comprised all available complete
genome sequences of HBV available initially in October 2004 from GenBank,
EMBL, and DDBJ. Sequences were screened to exclude patents, artificial mu-
tants, and identical entries. The remaining sequences were aligned manually in
the Simmonic sequence editor package (available from http://www.polio.vir.gla
.ac.uk). From the initial download, identical sequences or sequences showing less
than 1% sequence divergence from each other were removed, leaving a total of
526. Using genotyping information in the original sources, or through analysis of
the hepatitis B surface antigen gene, these sequences comprised 79 genotype A,
80 genotype B, 161 genotype C, 56 genotype D, 6 genotype E, 23 genotype F, 8
genotype G, and 7 genotype H sequences. A further 13 and 30 complete HBV
genome sequences from chimpanzees and gibbons/orangutans, respectively, were
added to the study data set, along with the divergent HBV variant (NC_001896)
from the woolly monkey (used as an outgroup in most subsequent phylogenetic
analyses).
Sequence selection. To ensure as fair a weighting as possible in the analysis of
sequence groups and recombination, several complete genome sequences of the
overrepresented genotypes A to C were removed by similarity scanning. This
ensured that the sequences used for analysis were both representative and max-
imally informative phylogenetically. After recombinant sequences were removed,
target numbers of approximately 40 to 60 sequences from each of the three
genotypes were obtained by excluding sequences with similarity thresholds of
below 1.5% over aligned complete genome sequences for genotype A and B
sequences (leaving 43 and 52, respectively) and 2.5% for genotype C (leaving 64).
Genotype B sequences were further divided by exclusion of B/C recombinants
(Ba genotype [26]) to leave 24 nonrecombinant variants (corresponding to Bj).
For other genotypes (including those from primates), all available sequences
were used, although genotypes unavoidably differed from each other in their
intragenotype variability. These sequences comprised set A and were used for
group scanning analysis. Consensus sequences from each group (50%) were used
for SIMPLOT.
After the initial analysis, a second download of sequences published from
October 2004 until June 2005 was carried out, and using the selection criteria
described above to eliminate closely related sequences, the following sequences
were combined to form set B: genotype A, 45; genotype B (nonrecombinant), 25;
genotype B/C recombinants (recB), 51; genotype C, 70; genotype D, 59; genotype
E, 13; genotype F, 25; genotype G, 9; and genotype H, 9 sequences. No further
nonhuman primate-derived sequences were available. A full listing of sequences
in sets A and B and recombinant sequences identified in the study is available
from the authors.
Assignment of recombinant forms of HBV. HBV variants were assigned as
confirmed intergenotype recombinants where there was published evidence for
their sequences having been obtained from two or more clones demonstrating
identical recombination breakpoints or from variants with identical breakpoints
described in separate studies or from different HBV-infected study subjects in
the same study. The remaining sequences were assigned as provisional recom-
binants. For these variants, there was insufficient published or unpublished data
to formally rule out the possibility that the complete genome sequences were not
composites of fragments amplified from samples of individuals with mixed ge-
notype infections.
RESULTS
Phylogenetic relationships between HBV genotypes. To visual-
ize phylogenetic relationships in different parts of the HBV ge-
nome, a new method was developed to record positions of each
sequence in a series of phylogenetic trees generated by sets of
overlapping fragments across the genome. Sequence fragments of
250 bases, incrementing in 25-base steps were used (125 trees in
total) (Fig. 1). Boot-strapped phylogenetic trees were constructed
using the programs SEQBOOT, DNADIST, NEIGHBOR, and
CONSENSE in the PHYLIP version 3.62 package (10). The
sequence data set comprised a total of 348 human and ape HBV
sequences (set B) from which all recombinant sequences had
been excluded with the exception of B/C recombinant sequences
(recB) (Fig. 1, bright green).
The vertical ordering of sequences in each tree was determined
by the following criteria. (i) Each tree was permuted to match as
closely as possible the sequence order of the tree generated from
the immediately preceding fragment. (ii) Allowable permutations
comprised branch rotations and positional reordering of se-
quences or groups of sequences, provided this occurred within
groupings below the specified bootstrap threshold value (70% for
the analyses shown in Fig. 1). (iii) Each tree was rooted using the
woolly monkey HBV sequence (NC_001896), whose position was
predefined at position 1.
The ordering of sequences in sequential trees according to
the above rules was automated in the program TreeOrder Scan
in the Simmonic 2005 version 1.4 Sequence Editor package
(which contains full information on required files and output
formats). The output of the program comprises a numeric
array that records the position of each sequence (columns) for
each tree (rows). Each line in the graph (Fig. 1), representing
the position of each sequence across the genome, was color
coded by genotype (see left and right columns). Because the
algorithm attempts to match sequence order between frag-
ments, alterations in the tree order of individual sequences and
of whole genotypes between fragments indicate changes in the
phylogenetic relationships of clades supported by bootstrap
values, in this case, of 70% or greater. For sequences with
constant phylogenetic relationships across the genome, each
sequence would follow a horizontal line across Fig. 1. In con-
trast, phylogenetic relationships between many genotypes
changed frequently in different parts of the genome.
First, there were differences between sequence fragments in
the degree of phylogenetic differentiation between genotypes,
with clear delineation of genotypes in some cases in bootstrap-
supported clades (delineated by black dividing lines). In other
cases, such as between positions 1600 and 1850 (corresponding
to the region of the genome encoding the X gene), sequences
of genotypes C, A, E, D, and B were phylogenetically undif-
ferentiated at the 70% bootstrap threshold level.
Second, phylogenetic relationships between genotypes
changed frequently, leading to several forced alterations in
branching order. For example, genotype D became an out-
group for all genotypes except genotypes F and H between
positions 780 (end of the S gene) and 980. Genotype G moved
to a similar outlier position from 980 to 2750. Genotype B se-
quences split at position 1950 (start of core gene), with the ma-
jority (recB) grouping with genotype C sequences and rejoining
the others at around position 2500 (end of core gene). A similar
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change in phylogenetic relationships was observed between geno-
types D and E. These genotypes were phylogenetically distinct
over most of the genome, but genotype E fell within the genotype
D clade in the core gene (positions 1950 to 2500). Genotypes F
and H did not invariably form separate clades (350 to 500). Fi-
nally, sequences from orangutans are interspersed with gibbon
sequences throughout the genome except for the pre-S1 and
pre-S2 regions where they were distinct.
Overall, the major phylogenetic discontinuities detected in
the TreeOrder Scan were at positions 750, 900, 1600, 1950,
2500, 2650, and 2750. Most of these occurred at, or close to,
gene boundaries and frequently occurred independently in dif-
ferent genotypes. Particularly frequent changes in phylogenetic
relationships were found at each end of the core and surface
genes. Since the grouping of many genotype B sequences in the
genotype C clade in the core gene has been previously inter-
preted as evidence for intergenotype recombination, this pro-
cess plausibly accounts for other changes in tree order evident
in the scan.
Screening for HBV recombination. To further investigate
the potential of recombination in the phylogenetic discontinui-
ties observed between HBV genotypes, a complete catalogue
FIG. 1. TreeOrder Scan of nonrecombinant HBV and recB sequences, showing positions of individual sequences (y axis) in phylogenetic trees
generated from sequential 250-base sequence fragments, incrementing by 25 bases (midpoints indicated in x axis). Changes in sequence orders
resulting from changes in phylogeny at the 70% bootstrap level are shown. Sequences are color coded by genotype, as indicated by labels in left
and right margins: genotype A, red; B, light green; recB (rB), green; C, yellow; D, blue; E, purple; F, pink; G, pale yellow; H, brown; chimpanzee
(Ch), gray; gibbon (Gi), white; orangutan (Or, turquoise; woolly monkey (outgroup on line 1), black. The recombinant sequence, AY161141, is
shown as a dotted line. The boundaries of sequence groupings with 70% or greater bootstrap support are indicated with black horizontal lines; for
clarity, only clades with six or more members were demarcated. All sequence positions were numbered relative to the HBVADW2 reference
sequence (length, 3,221 bp). For comparison, the TreeOrder Scan was aligned with a scale genome diagram of HBV (upper panel) and with
positions of breakpoints in recombinant HBV variants (triangles in lower panel). Each independent breakpoint is indicated as a square, localized
to one of 61 separate 250-base sequence fragments spanning the genome, with segment 62 representing the junction between the beginning and
end of the alignment. Genotype transitions are shown in the upper-left and lower-right quadrants of the square and are color coded as for the
TreeOrder Scan; unfilled triangles represent unknown genotypes; gibbon sequences are in black.
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of recombination breakpoints among previously published
HBV sequences was compiled. All sequences available in the
GenBank database in June 2005 were screened using the pro-
gram TreeOrder Scan incorporating the previously shown data
set of nonrecombinant sequences as controls (set B; n  347).
The TreeOrder Scan provides a rapid method to detect in-
tergenotype recombination among individual sequences. To
demonstrate this, a previously undescribed recombinant se-
quence AY161141 was included in the data set (Fig. 1). This
sequence fell within the genotype A clade (red) throughout the
genome except for the core gene, where it grouped with geno-
type D (blue). This method was applied using several sets of
downloaded sequences for rapid, large-scale initial screening
of all published HBV sequences for recombination.
Sequences identified as recombinant or potentially recom-
binant because of changes in branching order relative to the
control groups were further analyzed using SIMPLOT, version
2.5 (23), and a newly developed program called Group Scan
available in the Simmonic Sequence Editor package. The latter
program records how deeply embedded a test sequence lies
within each of the clades formed by standard phylogenetic
analysis of preassigned groups (nonrecombinant HBV geno-
types in set A, excluding recB sequences), from which it cal-
culates a grouping score (Fig. 2). The method for scoring is
related to that used by the Association Index, a method devel-
oped previously to quantify the degree of segregation of dif-
ferent predefined groups (6, 47).
For the Group Scan, the grouping score of a test sequence in
a phylogeny is computed by reference to the assigned groups of
its nearest neighbors in unrooted trees. Grouping scores (G)
for a predefined group, a, can be represented by the following
formula:
Ga 
1
y1/2N (1)
where N is the number of nodes separating the test sequence
from each member of the group, and y is the total number of
sequences in group a. By definition, the total of grouping
scores of each preassigned group, Ga to Gn, adds up to 1. For
robustness, each score is the mean of a predefined number of
bootstrap replicate trees (100 in the analyses shown) generated
from permuted data sets where either the nucleotide sequence
data (using SEQBOOT in the PHYLIP package) or the pop-
ulation (selection of a random two-thirds of sequences from
each preassigned group) is resampled. To localize sites of po-
tential recombination, consecutive fragments of predefined
length and incremental steps between fragments were analyzed.
For each fragment (midpoint plotted on x axis), the depth of
grouping in each genotype was plotted (y axis) with values ranging
from close to 0 (no grouping) to close to 1 (deeply buried within
a clade formed by sequences of a genotype). Changes in genotype
grouping, potentially arising from recombination, are character-
ized by abrupt changes in grouping values of the sequence, as
shown for AY161141 (Fig. 2A). Concordant with its changing
position on the TreeOrder Scan (Fig. 1), this sequence fell within
FIG. 2. (A) Comparison of Group Scanning and SIMPLOT analysis of the recombinant sequence AY161141. In each case, sequence fragments
of 250 bases incrementing by 50 bases, 100 bootstrap replicates, were compared with sequence groups (Group Scan) or 50% consensus sequences
of the eight human genotypes and four primate genotypes (color coded as described in the legend of Fig. 1). For the group scanning analysis, only
values of 0.5 indicate grouping within a genotype group. (B) Group Scan analysis of examples of newly discovered recombinant HBV variants
(listed in Table 1) and of novel recombinant sites in a previously analyzed sequence, HBVDNA. (C) Group Scan and SIMPLOT analysis of the
sequence AB048704. Because the recombinant region in the S gene was relatively phylogenetically uninformative, longer sequence fragments of
400 bases incrementing by 15 bases (Group Scan) or 20 bases (SIMPLOT) were analyzed. Sequences are color coded as described in the legend
of Fig. 1, except that the gibbon HBV variants are shown in black. The closely related variant, AB048705, produced comparable results (data not
shown).
TABLE 1. Compilation of recombinant HBV sequences
Sequencea Genotypes Breakpoint Reference(s)e
AF297621 A, D 4 34
HBVDNA D, A 4 4, 26, 5
HBVAYWCI D, A 4 26, 5
HBVAYWE D, A 2 26, 5
AF297619 D, A 4 34
AF297620 D, A 4 34
AY236161b D, A 2 Unpublished (U1)
AY161141,
AY161146
A, D 2 Unpublished (U2)
AY161149 A, D 6 Unpublished (U2)
AF418681 D, A 2 Unpublished (U3)
AB194949 A, E 2 20
AB056516 A, G 2 18
AY057947 C, A 2 7
RecB (Ba) B, C 2 5, 26, 30, 40
HPBADRM C, B 2 26, 27
AB031265 C, B 2 52
AF233236 C, B 2 Unpublished (U4)
AY057948,
AY817511
D, C 2 7, 48
AF461043,
AY817515,
et al.
D, C 2 Unpublished (U5), 48
AF241408,
AF241409
Uc, C 2 16
AB214516 F, C 2 Unpublished (U6)
AB048704,
AB048705
C, Gibbond 2 38 f
AF498266 C, Chimp 2 25, 45
AB046525 Chimp, U 2 42
a Accession numbers of sequences reported as recombinant previously and/or
found to be recombinant in this study. Each line contains variants with separate,
phylogenetically independent breakpoints.
b HBV sequences provisionally assigned as intergenotype recombinants shown
in italics (see Materials and Methods).
c U, unknown genotype.
d Assignment was based on the Group Scan and separate phylogenetic analysis
(Fig. 3).
e Published sources of recombinant sequence or description of recombination
or attributions for unpublished (U) sequences are as follows: G. Raimondo, T.
Pollicino, and G. Raffa for U1; C. Vaishali, S. K. Acharya, and S. K. Panda for
U2; V. Chaudhuri, S. K. Acharya, and S. K. Panda for U3; T. Cheng, M. Chen,
J. Zhang, and N. S. Xia for U4; W. J. Huang, H. Y. Zhang, Y. C. Wang, J. X. Lin,
W. J. Gu, X. Wu, and H. Y. Lan for U5; H. Tran and K. Abe for U6.
f Not reported as recombinant in original publication.
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the genotype A clade between positions 2400 to 1650 (values of
0.5; i.e., mean values for the 50 bootstrap replicated trees lay
within the outgroup value) and within the genotype D clade from
1700 to 2400. The underlying methodology of the Group Scan is
different from SIMPLOT, which records the bootstrap value of a
test sequence with artificially generated consensus sequences of
each genotype. However, the output from both programs is fre-
quently comparable, with evidence for alternate groupings of the
AY161141 sequence with the genotype A (consensus) sequence
between positions 2400 to 1600 and with genotype D between
1800 to 2400 (Fig. 2A), as found in the Group Scan.
A detailed comparison of the two methodologies will be
presented elsewhere; for the purposes of the current study,
both methods were used to scan recombinant and potential
recombinant sequences in data set A of HBV complete ge-
nome sequences (Table 1). Only breakpoints identified by both
methods were included in the analysis, since inconsistencies
between methods (such as the apparent recombination site
between genotypes A and G at position 700 in the SIMPLOT
analysis of AY161141) (Fig. 2A) may represent artifacts, in this
case arising from a more general change in phylogenetic rela-
tionships between genotypes at the end of the surface gene.
However, in general, the methods produced concordant results
for almost all recombination sites.
The screening carried out on GenBank sequences indepen-
dently identified all recombinant sequences described to date
in the HBV literature (Table 1). However, the analysis in this
study identified a series of previously undescribed recombinant
forms, including several A/D recombinants, a C/B, a D/C, and
an F/C recombinant from Bolivia (Fig. 2B). For the sequence
HBVDNA, reported as a D/A recombinant (4), there was
evidence from both Group Scanning and SIMPLOT for addi-
tional recombination points between 1300 and 1450 (Fig. 2B).
For the sequences, HPBADW1 and HBVP4PCXX, which
have previously been described as recombinant (4, 5, 26), nei-
ther group scanning nor SIMPLOT identified clear break-
points, and these sequences have therefore been omitted from
subsequent analysis.
Finally, the Group Scan identified AB048704 and AB048705
from Vietnamese HBV patients as potential gibbon/genotype
C recombinants (Fig. 2C and 3) (the only published analysis of
them was carried out before the gibbon-derived sequences
were available). Between positions 300 and 1000, both se-
quences either formed outgroups of or fell within the gibbon
clade (grouping values of 0.5). The grouping of AB048704
and AB048705 with gibbon-derived variants was confirmed by
separate phylogenetic analysis, where both sequences (along
with those from orangutans) clearly fell within the gibbon
sequence clade (Fig. 3). Because this region of the S gene is
relatively phylogenetically uninformative, SIMPLOT failed to
record high bootstrap scores in the recombinant region, al-
though the analysis confirmed a change in grouping from ge-
notype C to gibbon and back at the same breakpoints identified
by the Group Scan (Fig. 2C).
For analysis of breakpoint positions, it was apparent that
many recombinant HBV variants were phylogenetically related
and contained identical recombination sites (such as among
the widespread B/C recombinant form in East Asia and the
newly discovered D/C recombinants, such as AY057948 and
AY817511 from Tibet and China [7, 48]). Therefore, only
FIG. 3. Phylogenetic analysis of positions 251 to 650 (correspond-
ing to the putative recombinant region in the S gene) (Fig. 2C) of
sequences AB048704 and AB048705 (Rec), all available gibbon- and
orangutan-derived sequences, and nonrecombinant human- and chim-
panzee-derived HBV variants (set A). Since sequences from each
genotype were monophyletic, only the most recent common ancestor
(MRCA) is shown for non-gibbon genotypes. The tree was constructed
by neighbor-joining using Jukes-Cantor corrected distances in the
MEGA2 package (19), using 200 bootstrap replicates (values of 70%
or greater shown).
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HBV variants that showed clearly different breakpoints and/or
genotype composition were included in subsequent analysis to
ensure that the recombination events were phylogenetically
independent and not multiply scored. Breakpoints were local-
ized to the segment (from a total of 62) where grouping or
bootstrap values crossed the threshold 0.5 value for the two
sequences. The positions of the breakpoints were aligned with
the HBV genome diagram and with the TreeOrder Scan of
nonrecombinant sequences (Fig. 1).
Overall, the distribution of recombination breakpoints was
nonrandom, with certain apparently favored sites (such as frag-
ment 14 [positions 650 to 900]), where several different recom-
bination events between different genotypes occurred (be-
tween genotype A and D variants, as well as between D and C).
Favored recombination sites frequently localized to gene
boundaries, such as the end of the S gene (fragment 14), the
precore/C gene start, the end of C gene, and the pre-S1/pre-S2
junction. Elsewhere, however, breakpoints were more ran-
domly distributed, such as between fragments 19 and 32 (the 3
end of the P gene and the X gene).
Recombination within HBV genotypes. Apart from the changes
in branching order of different genotypes and the multiple exam-
ples of phylogenetically independent recombinant events (previ-
ous sections), further evidence for recombination was provided by
changes in tree order between consecutive fragments among vari-
ants conventionally regarded as nonrecombinant. For example,
following the tree position of individual genotype A (red) and D
(blue) sequences across the genome (Fig. 1) reveals several sites
where positions change in response to changes in phylogenetic
relationships between members of the same genotype.
To investigate whether these violations of intragenotype
phylogenies between fragments arose more frequently than
would be expected by chance, frequencies of sequence order
changes within genotypes were compared with those of artifi-
cially generated, nonrecombinant control data sets of se-
quences corresponding exactly in sequence divergences be-
tween native sequences. A total of 50 independently replicated
data sets of the original 311 native sequences in set A were
created using a maximum likelihood method implemented in
the program EVOLVER in the PAML package (51), with
likelihood-derived parameters for the model, rate variation
between sites, frequencies of invariant sites, and sequence
changes in different model categories. Separate analysis was
also carried out on separate subsets of certain HBV genotypes
that contained more than 20 representative sequences (A, B,
recombinant B/C [recB], C, D, F/H combined, and Gibbon).
Phylogeny violations in native and control data sets were cal-
culated as the mean number of tree order changes observed on
pairwise comparison of each sequence fragment, normalized
by the number of sequences, using a range of bootstrap thresh-
old values (Table 2).
For all meaningful bootstrap threshold values (i.e., equal to
or greater than 50%), higher frequencies of phylogeny viola-
tions were observed in native genotype A, D, F/H, and gibbon
sequences compared with mean values for control data sets
(Table 2). To estimate the statistical significance of these dif-
ferences, the positions of native scores in the distribution of
those from control sequences was determined and expressed as
a Z score. Values of greater than 2 represent frequencies of
phylogeny violations outside the 95th percentile for the control
values (two-tailed test). Sequences within genotypes A, D, F/H,
and gibbon-derived HBV variants showed significantly greater
frequencies of phylogeny violations than would be expected by
chance (Z scores ranging from 3.4 to 7.7), while no significantly
greater tree order changes were found in genotype B, recB, or
C (Z scores of 0.1 to 0.94).
The number of phylogeny violations attributable to recom-
bination was calculated by subtracting the control from the
native value (Table 2, column 9); this indicated substantial
number of separate recombination events in genotype A, D,
and gibbon sequences, and none or close to none in genotypes
B, recB, and C. Frequencies of phylogeny violations were fre-
quently, but not invariably, greater among the more divergent
genotypes (measured as mean intragenotype pairwise dis-
tance) (Table 2, column 3). Although carried out as a separate
analysis, the number of phylogeny violations in the whole data
set of 312 sequences of all genotypes (n  110) approximated
to the total number of events from the individual genotypes
analyzed (n  119). As expected, repeating the analysis using
higher bootstrap threshold values recorded progressively fewer
TABLE 2. Phylogeny violations within HBV genotypes
Group No. ofsequencesa
Divergence
(%)b
No. of violations/sequencec
Z scoree Pe Total no. ofviolations fNative Control SDd
A 39 4.1 0.364 0.190 0.038 4.65 4  106 40
B 24 2.7 0.152 0.109 0.039 1.03 NS 6
RecB 47 3.0 0.116 0.118 0.029 0.07 NS 1
C 64 4.0 0.148 0.147 0.031 0.05 NS 1
D 52 2.9 0.235 0.149 0.031 2.78 0.005 26
F/H 30 3.3 0.314 0.216 0.042 2.33 0.02 17
Gibbon 28 6.7 0.380 0.180 0.042 4.42 1  105 30
All 310 3.4 0.206 0.143 0.013 4.91 9  107 110
a Number of sequences compared within genotype.
b Mean, uncorrected pairwise distance between sequences within genotype.
c Number of phylogeny violations per sequence per 1,000 bases using a 60% bootstrap value. For controls, mean number of 50 nonrecombinant control data sets is
shown. For this analysis, fragments were 400 bp in length, overlapping by 200 bases (16 fragments per genome).
d Sampled standard deviation of 50 nonrecombinant control data sets.
e Data sets with significantly greater frequencies of phylogeny violations than expected by chance (P  0.05) are indicated in bold. NS, not significant.
f Total net (number of native  number of control) number of phylogeny violations within each sequence group.
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recombination events (for the whole data set: 62 at 70%, 52 at
75%, 44 at 80%, and 28 at 90%) but retained disparities in
phylogeny violations between native and control data sets for
each genotype (Z scores for whole data set of 4.91 at 60%, 3.44
at 70%, 3.15 at 75%, 2.6 at 80%, and 2.43 at 90%).
The locations of phylogeny violations in gibbon-derived HBV
sequences were determined by plotting frequencies for individual
pairwise comparisons of fragments in the form of a half-diagonal
phylogenetic compatibility matrix (Fig. 4). This analysis reveals
several regions of low values (blue) where phylogenies were com-
patible, interrupted by often sharp boundaries (arrows) splitting
sequences into a series of noncompatible blocks. In two of the
three indicated positions, these corresponded to favored sites of
recombination among intergenotype recombinant HBV variants
(Fig. 1, lower panel).
DISCUSSION
Intergenotype recombination. This study provides compre-
hensive information on the occurrence and composition of
HBV intergenotype recombinants. A total of 24 phylogeneti-
cally independent recombinant forms of HBV were found,
involving all human genotypes as well as both chimpanzee and
gibbon variants. From the available data on their geographical
distributions and the finding of the same recombinants from
different published sources, it is apparent that recombinant
forms are capable of spread in human populations and of
developing their own specific distributions and epidemiologies.
This is particularly clearly demonstrated for the B/C recombi-
nant, which now accounts for the majority of genotype B se-
quences in mainland Asia (39). Another example is the D/C
recombinant, found in a separate survey in Tibet (AY057948
[7]) and China (AY817511 [48]). While the current study is as
up to date as possible, clearly more extensive sampling and
sequence analysis are likely to reveal further examples of re-
combinant forms of HBV as a wider range of human popula-
tions are surveyed in the future.
Apart from documenting individual examples of intergeno-
type recombinants, this study provides evidence that the evo-
lution of what are conventionally regarded as “nonrecombi-
nant” genotypes of HBV has been accompanied by a similar
series of recombination events. This process is manifested most
clearly in the frequent changes in phylogenetic relationships
between genotypes across the genome in the TreeOrder Scan
at positions that frequently coincide with breakpoints in re-
combinant viruses (end of S gene, start of pre-S2, and both
ends of the C gene) (Fig. 1). For example, genotype G shows
regions where it is highly divergent in sequence from genotypes
A to E and primate viruses although in the S gene, genotype G
is approximately equidistant from genotypes A to E; in a third
region within the small S fragment, it becomes interspersed
with genotype A (250 to 350). Genotype E has a similarly
variable relationship with genotype D (interspersed in the core
gene and distinct elsewhere), as do genotypes F and H (posi-
tions 350 to 500) and gibbon and orangutan variants, which are
only phylogenetically distinct from each other in the pre-S1/S2
region.
Part of the difficulty with conceptualizing the recombination
process is that, in some cases, one or other of the ancestral
HBV variants involved in a recombination event may be miss-
ing from the data set. In the simple case, the widely distributed
recombinant virus, recB, has readily identifiable parents as the
genotype B and C nonrecombinant forms (5, 26), both of which
still cocirculate in Asia with recB (40). However, a potentially
analogous recombination process may have occurred between
genotypes D and E, although in this case, the putative ancestor
genotype E sequence with a phylogenetically distinct core gene
sequence has become rare or extinct and therefore not iden-
tifiable as a recombination parent. That both genotype E and
recombinant B/C sequences are each monophyletic in the core
region (although contained within the genotype D and C
clades) provides further evidence for their clonal origin from
discrete recombination events in the past. It is similarly likely
that genotype G is a recombinant virus between an ancestral
virus with S gene sequences comparable in divergence to those
between genotypes A to E and a much more divergent HBV
variant that contributed the rest of the genome (18, 36). An
abrupt change in phylogenetic relationships in indeed observed
in the TreeOrder Scan, where genotype G sequences (pale
yellow) migrated to an outlier position between positions 950
and 2750 (Fig. 1). This observation is consistent with previously
observed differences in pairwise distances or phylogenetic trees
of different genes of genotype G and other HBV variants (18,
36). An analogous process of core gene replacement with a
much more divergent HBV variant has been shown to have
occurred in the chimpanzee HBV variant, AF498266 (Table 2)
(25, 45).
FIG. 4. Phylogenetic compatibility matrix of gibbon-derived HBV
sequences, showing frequencies of phylogeny violations for each pair-
wise comparison of sequence fragments. Frequencies are color coded
to indicate number of phylogeny violation per sequence (see key).
Phylogenetically compatible regions are shown as deep blue. Arrows
indicates the main sites where changes in phylogeny of the gibbon
sequences lead to regions of incompatibility between fragments. For
this analysis, sequence fragments of 400 bases, incrementing by 25
bases across the genome, were compared (117 fragments total), using
a bootstrap value of 70% above which phylogeny violations were com-
puted.
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Intragenotype recombination. Using novel analysis methods
based on recording frequencies of phylogeny violations be-
tween members of the same genotype, we have been able to
infer frequent recombination within genotypes A, D, and F/H
as well as among gibbon variants recovered from a variety of
species in Southeast Asia (Table 2; Fig. 3). Without any knowl-
edge of what the recombination partners might be within the
same genotype, it was nevertheless possible to show that their
tree order changed more frequently in native sequences com-
pared to controls that were matched for their sequence diver-
sity but were nonrecombinant in phylogeny. The frequencies of
recombination events varied by genotype, with frequent occur-
rences in genotypes A, D,F/H, and gibbon sequences but few if
any in genotypes B, recB, and C (Table 2, column 9). These
observations provide further evidence for large-scale recombi-
nation in the evolutionary history of several HBV genotypes.
Interestingly, the recB (B/C) recombinants (which were
monophyletic in the core region; see above) showed no evi-
dence for intragenotype recombination, in common with the
parental genotype C sequences (Table 2). The period over
which their current sequence diversity arose (mean pairwise
distances, 3% and 4%) indicates that the timescale for in-
tragenotype recombination can be extremely slow. For this
calculation, the rate of sequence change of HBV of 1.5 105
to 5 105 substitutions per site per year observed in hepatitis
B e antigen carriers (14, 32) is most likely to approximate to
the rate found among carriers infected through perinatal trans-
mission in Asia, where genotypes B, C, and recB predominate
(2, 13). The current sequence diversity within recB (3%) there-
fore corresponds to a period of 300 to 800 years of separate
evolution without fixation of detectable recombinant forms of
this genotype. Mother-to-child transmission and the establish-
ment of a persistent carrier state resistant to adult reinfection
may indeed be an epidemiological factor that reduces oppor-
tunities for recombination among these Asian genotypes (B,
recB, and C). The higher frequencies observed in genotypes A
and D may, in contrast, reflect greater epidemiological oppor-
tunities for recombination associated with horizontal transmis-
sion patterns later in life found in sub-Saharan Africa (41, 50)
and in Western countries where these genotypes predominate.
Recombination may also be favored over longer timescales
over which some genotypes may have circulated, such as the
more divergent gibbon HBV sequences (Table 2).
Recombination and the origin of HBV genotypes. The time
scales of HBV recombination implied by this analysis are
clearly compatible with the existence of geographically wide-
spread individual recombinants (such as the B/C variant in
Asia and genotype E in central Africa). Over this extended
timescale, individual recombinant forms of HBV may spread
and replace their ancestors and therefore obscure the se-
quence of recombination events that led to their origin (such as
hypothesized for genotype E). The evidence in this study for
frequent intragenotype recombination, combined with past
multiple recombination events with often divergent HBV vari-
ants, as shown by the TreeScan analysis, indicates that many of
the currently classified genotypes of HBV are themselves mo-
saics. The extraordinary difficulty in developing a plausible
timescale in the evolutionary history of HBV (3, 9) and under-
standing the relationship between human and nonhuman HBV
variants may be, at least in part, accounted for by the complex-
ity of the recombination events in their evolution (3).
While changes in the circulating pool of HBV variants are
clearly subject to stochastic events and complex epidemiolog-
ical factors (such as transmission route), their spread may be
enhanced by the evolution of changes in frequencies of persis-
tence and e antigen expression (37, 39, 40) generated though
recombination that enhance transmissibility. In the future, ob-
served differences in treatment responsiveness (1), combined
with the growing evidence for frequent coinfection with differ-
ent genotypes (15), may provide a further driving force for
recombination to generate resistant viruses. Recombination
potentially may therefore play a large, underestimated role in
both the origins of currently known genotypes of HBV found
in human and nonhuman primate populations and in the fu-
ture evolution of their pathogenicity and transmissibility.
Finally, the evidence for recombination between human and
ape HBV variants, such as the chimpanzee/genotype C recom-
binant (25, 45), and the evidence from group scanning for a
gibbon/genotype C recombinant among HBV variants in Viet-
nam (Fig. 2C and 3) have important implications for eradica-
tion and control measures for HBV. Their occurrence demon-
strates that human and nonhuman-associated HBV variants
can indeed share hosts in nature. The existence of widespread,
endemic infection in nonhuman primates and their potential
for cross-species transmission into humans will clearly hamper
efforts toward the ultimate goal of eradication of HBV infec-
tion in geographical regions where humans and apes share
habitats (35).
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